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Aims: Urocortin-2 (Ucn-2) is a potent cardioprotector against Ischemia and Reperfusion
(I/R) injuries. However, little is known about its role in the regulation of intracellular Ca2+
concentration ([Ca2+]i) under I/R. Here, we examined whether the addition of Ucn-2 in
reperfusion promotes cardioprotection focusing on ([Ca2+]i handling.
Methods and Results: Cardiac Wistar rat model of I/R was induced by transient
ligation of the left coronary artery and experiments were conducted 1 week after surgery
in tissue and adult cardiomyocytes isolated from risk and remote zones. We observed
that I/R promoted significant alteration in cardiac contractility as well as an increase
in hypertrophy and fibrosis in both zones. The study of confocal [Ca2+]i imaging in
adult cardiomyocytes revealed that I/R decreased the amplitude of [Ca2+]i transient and
cardiomyocytes contraction in risk and remote zones. Interestingly, intravenous infusion
of Ucn-2 before heart’s reperfusion recovered significantly cardiac contractility and
prevented fibrosis, but it didn’t affect cardiac hypertrophy. Moreover, Ucn-2 recovered
the amplitude of [Ca2+]i transient and modulated the expression of several proteins
related to [Ca2+]i homeostasis, such as TRPC5 and Orai1 channels. Using Neonatal
Rat Ventricular Myocytes (NRVM) we demonstrated that Ucn-2 blunted I/R-induced
Store Operated Ca2+ Entry (SOCE), decreased the expression of TRPC5 and Orai1
as well as their interaction in reperfusion.
Conclusion: Our study provides the first evidences demonstrating that Ucn-2 addition
at the onset of reperfusion attenuates I/R-induced adverse cardiac remodeling, involving
the [Ca2+]i handling and inhibiting the expression and interaction between TRPC5 and
Orai1.
Keywords: Urocortin-2, ischemia and reperfusion, adverse remodeling, Ca2+ dysregulation, store operated Ca2+
channels
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INTRODUCTION
Ischemic heart disease still remains the leading cause of death
worldwide, and STEMI is the most common type of heart
infarcts (World Health Organization, 2008). The majority of
patients with acute myocardial infarction are routinely treated
with pharmacological reperfusion therapy and/or widening the
vessel with angioplasty (Ribichini and Wijns, 2002). Actually,
an effective and early revascularization limits the extent of
myocardial necrosis and left ventricular dysfunction. However,
critical injuries occur when oxygen rich blood reperfuses the
vulnerable myocardial tissue, notably by extensive production
of the mitochondrial reactive oxygen species. This phenomenon
is known as I/R syndrome (Hausenloy et al., 2017). I/R
injuries usually lead to adverse cardiac remodeling and further
development of heart failure. The initial myocardial responses
related to the early adverse cardiac remodeling involve the loss of
cardiomyocytes, the hypertrophy of remaining cardiomyocytes as
well as changes in composition and distribution of components
of the extracellular matrix, especially the generation of collagen
and fibrosis extension to the not-infarcted myocardial remote
area (Pfeffer and Braunwald, 1990). Generally, heart failure
is characterized at the molecular level by dysfunction and
abnormalities of the handling of [Ca2+]i with significant
alteration in excitation-contraction coupling (Gómez et al., 1997;
Lehnart et al., 2009). Previous reports have shown that cardiac
dysfunction observed in patients with heart failure was related
to altered expression and activity of Ca2+-related proteins
(Kho et al., 2012). More recently, compelling evidences have
demonstrated that different cationic channels which permeate
Ca2+, such as TRPC and store operated Ca2+ channels (SOCC)
contribute to cardiomyopathies, cardiac fibrosis and cardiac
remodeling (Smani et al., 2015).
In the last decade, Urocortin peptides (Ucn-1, Ucn-2,
Ucn-3) belonging to the CRF family (Dautzenberg and Hauger,
2002), have emerged as a potential therapeutic agonists that
improved heart performances and protected it from I/R injuries
(Boonprasert et al., 2008). In heart, Ucn peptides bind to CRF-R2
receptor enhancing cAMP production (Brar et al., 1999) and
Protein Kinase A (PKA) activation (Calderón-Sanchez et al.,
2009). We have demonstrated recently that Ucn-1 activated the
other important effector of cAMP, Epac (Calderón-Sánchez et al.,
2016). Epac and ERK1/2 are also involved in the Ucn-1-induced
positive inotropism, in its regulation of apoptotic genes and
in microRNAs expression during heart reperfusion (Díaz et al.,
2017). A recent study has demonstrated that sustained activation
of Epac activated Ca2+ influx through store-operated Ca2+ entry
(SOCE) via TRPC3/4 channels (Domínguez-Rodríguez et al.,
2015). Here, we analyzed the potential protective effects of
the infusion of Ucn-2 in rat model of I/R before reperfusion,
Abbreviations: [Ca2+]i, intracellular Ca2+ concentration; CRF, corticotropin-
releasing factor; Epac, exchange protein directly activated by cAMP; I/R, ischemia
and reperfusion; LCA, left coronary artery; NCX, Na+/Ca2+ exchanger; NRVM,
Neonatal Rat Ventricular Myocytes; PLA, proximity ligation assay; SOCE,
store-operated Ca2+ entry; SOCC, store operated Ca2+ channels; SR, sarcoplasmic
reticulum; STEMI, ST-segment-elevation myocardial infarction; TRPC, transient
receptor potential canonical; Ucn-1/2/3, Urocortin peptides.
focusing on its effect in [Ca2+]i handling and its regulation of
Ca2+-related key proteins during adverse cardiac remodeling.
We demonstrate that Ucn-2 recovers significantly hemodynamic
parameters of heart subjected to I/R, prevents fibrosis and
decreases infarct size. Ucn-2 also improves the handling of
[Ca2+]i abnormalities caused by I/R and attenuates SOCE
through downregulation of TRPC5 and Orai1.
MATERIALS AND METHODS
All the experiments with animals were performed in accordance
with the recommendations of the Royal Decree 53/2013 in
agreement to the Directive 2010/63/EU of the European
Parliament and approved by the local Ethics Committee on
human Research of the “Virgen del Rocio” University Hospital
of Seville and the Animal Research Committee of the University
of Seville.
Induction of Rat Myocardial Infarction
and Reperfusion (I/R)
Male Wistar rats weighing 250 ± 50 g were anesthetized with a
mixture of O2/sevoflurane 2%, then with anesthesia (50 mg/kg
ketamine plus 8 mg/kg xylazine i.p) as described previously
(Díaz et al., 2017). A small animal ventilator was used (Harvard
Apparatus, Holliston, MA, United States) with a tidal volume
(Vt) of 1.5–2.0 ml and 75–80 ventilations per minute. A left
thoracotomy was performed in the intercostal space between
the third and fourth ribs, followed by a pericardiotomy. The
LCA was occluded with a 6-0 ProleneTM silk suture (Ethicon,
Spain) and tied off below the level of the left atria appendage
and over a small tube placed into the suture for the posterior
release of the occlusion, for a correct reperfusion. LCA occlusion
was confirmed by visual observation of cyanosis and ST-segment
elevation by continuous ECG monitoring. After 40 min of LCA
ligation, reperfusion was initiated by releasing the knot, removing
the tube and was confirmed by the appearance of epicardial
hyperemic and by ECG recovery. The chest cavity was closed and
the air was expelled from the chest, sevoflurane administration
was switched off and the animal was supplied with O2 until
reflexes were detected. Analgesia was induced with meloxicam
(1 mg/kg) administered subcutaneously. Rats were left on a
heating pad until fully conscious recovery.
For this study, we considered the following experimental
groups: Group 1 (I/R): ischemia was produced by LCA ligation
during 40 min and the administration of vehicle (saline 0.9%
NaCl) by tail vein injection 5 min before reperfusion. Group 2
(I/R + Ucn-2): ischemia was produced by LCA ligation during
40 min and an intravenous (i.v.) dose of Ucn-2 (150 µg/Kg)
was administered by tail vein injection 5 min before reperfusion.
Group 3 (Sham): operated rats underwent the same surgical
procedure without coronary ligation. The same volume of vehicle
(saline 0,9% NaCl) was administrated by tail vein injection.
Animals were randomly subjected to either LCA ligation
or sham operation (5% mortality during the interventions).
The survival rate in all groups after Ucn-2 or saline treatment was
95–100%.
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Echocardiography
Transthoracic echocardiographic analyses were performed using
VevoTM 2100 ultrasound system with transducer MS250
with a frequency range of 13-24 MHz (VisualSonicsTM,
Toronto, ON, Canada). The cardiac function was analyzed
after surgery in light anesthetized rat with 2% sevoflurane.
Breath and heart rate as well as rectal core temperature
were monitored. A water heater and a heat lamp were used
to keep the temperature around 37◦C. M-Mode images of
the left ventricle at the level of the papillary muscles were
obtained, and different functional hemodynamic parameters
were evaluated. Images acquisition and analyses were done in a
blind manner.
Cardiovascular Magnetic Resonance
The cardiovascular magnetic resonance study was performed
with the imaging system ICON 1T (Bruker, Rheinstetten,
Germany) using a rat whole body coil. Animals were sedated
by sevoflurane (2–4%) and monitored by electrocardiogram and
rectal thermometer, checking the maintenance of appropriate
physiological and hemodynamic conditions (heart rate between
400 and 500 beats per minute, respiratory rate 60–100 breaths
per minute and body temperature > 35◦C). To evaluate heart
function, images were collected with a T1-weighted spin echo
cine sequences and synchronized with the ECG (repetition
time: 15 ms, echo time 2 ms, resolution: 0.234 × 0.234 mm,
slice thickness: 1.25 mm, 6–7 consecutive cuts without spacing
between them) in short-axis plane from baseline to the height
of the mitral valve to the left ventricular apex. Subsequently,
to quantify the ischemic area, images were collected with
gradient echo T1 sequences and synchronized with the ECG
(repetition time: 100 ms, echo time: 2.5 ms, resolution:
0.234 × 0.234 mm, slice thickness: 1.250 mm, angle of
rotation: 75◦ or 90◦, 2 cuts with the same geometry as the
previous film sequences) to approximately 15 min after the
introduction of a gadolinium-based contrast which highlights
fibrotic areas.
Infarct Size Determination
After intraperitoneal injection of pentobarbital sodium
(100 mg/Kg), cardiectomy was done 1 week after surgical
intervention. Hearts were immersed in cold 1x PBS to be
clean of blood. Then, they were frozen during 1 h and a half
at −20◦C and sliced in 2 mm. The slices were immersed in a
solution of 1% Triphenyltetrazolium Chloride (TTC) in PBS
at 37◦C during 30 min. The healthy myocardium shows an
intense red color because of the redox activity of dehydrogenases;
meanwhile the necrosed area remains white. The heart slices were
photographed and the areas of infarction were quantified using
ImageJ (NIH, United States). The infarct size was measured
as a percentage of total left ventricle at the level of papillary
muscles.
Cardiomyocyte Area
Wheat Germ Agglutinin (WGA) staining was used to assess
cardiomyocyte cross-sectional-area as previously described
(Söderberg et al., 2008; Bensley et al., 2016). Paraffin heart
sections (6 µm) were de-waxed and rehydrated 3 times
with xylene and further washed with ethanol. Then, they
were washed 2 min in running water before the staining.
Heart sections were stained with WGA-Alexa Fluor 488 (Life
technologies, United States) at 10 µg/ml as well as DAPI
(Vector Labs, United States) at 1 µg/ml, both prepared in
PBS. WGA-AF488 selectively binds to N-acetylglucosamine and
N-acetylneuraminic acid (sialic acid) residues highlighting the
cell membrane of cardiomyocytes. DAPI was used as a cell
nuclei marker. After staining, slides were washed twice during
2 min with PBS and mounted using Fluorescence Mounting
Medium (Dako, United States). Images were acquired with
40X magnification in confocal microscope Nikon A1R+ (Japan)
and the cross-sectional area of cardiomyocytes was quantified
with NIS-Elements software (Nikon, Japan). Cardiomyocytes
were selected for analysis only when their nuclei were seen
in the center and their sarcolemmal membranes were well
identified. The cross-sectional area of >200 cardiomyocytes was
measured.
Cardiomyocytes Isolation and [Ca2+]i
Study
Ventricular myocytes were isolated using collagenase type
II (251 IU/mL; Worthington Biochemical, Lakewood, NJ,
United States) as described previously (Domínguez-Rodríguez
et al., 2015). The hearts were removed and perfused on a
Langendorff perfusion apparatus. After perfusion, hearts were
left in Petri dishes containing enzyme solution supplemented
with 2 g/L Bovine Serum Albumin (BSA) and cut up into
two regions of interest: the (non-infarcted) remote zone and
(infarcted) risk zone as previously described (Driesen et al.,
2007; van Rooij et al., 2008). As shown in Figure 1A, the
areas below and adjacent of the LAD ligature were considered
risk areas (highlighted by red color), whereas the non-
infarcted remote zones were considered areas above the LAD
ligature as indicated by the green color in Figure 1A. Both
zones were gently stirred for 2–3 min at 37◦C to disperse.
Isolated cells were then filtered, centrifuged and suspended
in Tyrode solution containing (in mM): 130 NaCl, 1 CaCl2,
0.5 MgCl2, 5.4 KCl, 22 glucose, 25 HEPES, 0.4 NaH2PO4,
5 NaHCO3; pH was adjusted to 7.4 with NaOH. Cells were
plated in control solution containing 1.8 mM CaCl2 at 37◦C
and experiments were performed on Ca2+-tolerant rod-shaped
myocytes at 37◦C.
Isolated ventricular myocytes were loaded with Fluo-3 AM
(6 µM) for 30 min, as described previously (Domínguez-
Rodríguez et al., 2015). Only rod-shaped cells, quiescent
when unstimulated were used for the Ca2+ experiments
performed at room temperature (24–26◦C) and under control
Tyrode perfusion. Confocal Ca2+ images were obtained
with confocal microscope (Leica SP5, objective w.i. 63x)
by exciting cells at 500 nm and emission was collected at
>510 nm using a white light laser in the line-scan mode.
To record transients of [Ca2+]i, Fluo-3 loaded myocytes
were excited at 1 Hz by electrically field stimulated using
two parallel Pt electrodes until steady state before recording.
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FIGURE 1 | Urocortin-2 recovers cardiac contractility and reduces infarct size 1 week after I/R. (A) Experimental protocol for in vivo I/R animal model infused or not
with Ucn-2. Tissue was isolated from remote (green area) and risk (red area) as drawn in right. (B) Representative M-mode echocardiographic images evaluated
1 week after surgery. Images are from “Sham” (n = 8); “I/R” rats (n = 15); and I/R rats infused with Ucn-2 (150 µg/Kg) before reperfusion (n = 14). (C,D) Bar graphs
summarize Ejection Fraction (EF, %) and Shortening Fraction (SF, %) measured in same experimental groups as in (B). Black bar is for “Sham”; gray bar is for “I/R”;
and hatched gray bar is from “I/R + Ucn-2”. (E) Representative TTC stained transverse heart sections from I/R ± Ucn-2 rats. White area indicates necrosis. Bar
graph in right shows the average of the infarct size (%). Values are mean ± SEM. ∗ Indicates significance at p < 0.05.
To obtain F/F0 fluorescence’s values (F) were normalized by
the basal fluorescence (F0). For SR Ca2+ load estimation,
intact cardiac myocytes were rapidly perfused with 10 mM
caffeine right after field-stimulation in order to empty
SR. The amplitude of caffeine-evoked intracellular Ca2+
transient (F/F0) was used to assess SR Ca2+ load. Data were
analyzed by IDL software (Exelis Visual Information Solutions,
United States).
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Neonatal Rat Ventricular Myocytes
Primary Culture
Neonatal rat ventricular myocytes were isolated from hearts
of 1- to 3-days-old Wistar rats (Sabourin et al., 2016). The
auricles were discarded and ventricular cells were dispersed
by successive enzymatic digestion with 0.125% trypsin-DNAase
(Sigma-Aldrich, United States). NRVMs (1 × 106/ml) were
seeded into plates. Primary ventricular cardiomyocytes were
cultured in Dulbecco’s Modified Eagle Medium DMEM/medium
199 (4:1) supplemented with 10% horse serum, 15% fetal
bovine serum (FBS, Thermo Fisher Scientific, United States), 1%
glutamine, 100 U/ml penicillin and 100 µg/ml streptomycin for
24 h. On the next day, the medium was changed. Approximately
48 h after isolation, cells displayed as confluent monolayer
with spontaneous contractile activity. Then, isolated cells were
cultured in medium until their use.
NRVMs Transfections and Urocortin-2
Treatment
Neonatal rat ventricular myocytes were transfected with siRNA
using Lipofectamine R© RNAiMAX Transfection Reagent (Thermo
Fisher Scientific, United States) when they were 70–80% of
confluence according to the manufacturer’s instructions. Briefly,
we diluted 5 µl of Lipofectamine RNAiMAX Reagent in 150 µl
of Opti-MEN R© Medium (Gibco). Then, we added 3 µl at
10 µM of siRNA of TRPC5 (Dharmacon, United States) and
Orai1 (Ambion, Thermo Fisher, United States). Preparations
were mixed in 1:1 proportion and incubated for 5 min at
room temperature. Finally, we added siRNA-lipid complex to
cell culture. Cells were kept in culture for further 48–72 h and
BLOCK-iTTM Alexa Fluor R© Red MEM R© Medium was replaced
each 24 h. BLOCK-iTTM Alexa Fluor R© Red (Thermo Fisher
Scientific, United States) was added as positive control to
visualize the efficiency of cells transfection.
Neonatal rat ventricular myocytes were incubated in a
simulated ischemic solution (mM): 142 NaCl, 3.6 KCl, 1.2 MgCl2,
1.8 CaCl2, 5 NaHCO3, 20 Hepes, 20 Lactate-Na, 20 sucrose
(pH 6.22), then placed in an incubator of hypoxia at 1% O2
and 5% CO2. Reperfusion was restored by the removal of the
ischemic solution and cells incubation an incubator at 21% O2
and 5% CO2.
We considered the following experimental groups: Group 1
(Control): Untreated NRVMs. Group 2 (I/R): After stabilization
in control solution, NRVMs were exposed to simulated ischemia
solution during 3 h and reperfused for 72 h with freshly control
solution. Group 3 (Ucn-2): Same as group 2, but Ucn-2 (10 nM)
was added during ischemia. Group 4 (Ucn-2 + Ast): Same as
group 3, but Ucn-2 was added in presence of astressin (500 nM),
CRF-R2 specific inhibitor.
In Situ Proximity Ligation Assay
Spatial co-localization of TRPC5 and Orai1 were analyzed
with PLA technique in NRVMs cell culture. The method used
the Duolink in situ PLA detection kit Red (Sigma-Aldrich,
United States) as previously described (Söderberg et al., 2008).
NRVMs were seeded in a six-channel plate and fixed with
100% cold methanol during 5 min. After blocking for 30 min
with 1% BSA and 3% heat-inactivated goat serum in PBS, cells
were incubated with primary antibodies (rabbit anti-TRPC5,
1:50 (Dharmacon, United States) and mouse anti-Orai1, 1:100
(Novus Biologicals, United States) for 2 h at room temperature.
Then, the probes Duolink PLA anti-rabbit PLUS and anti-mouse
MINUS were added for 1 h at 37◦C. The secondary antibodies
of these probes were attached to synthetic oligonucleotides,
which hybridize when they are in close proximity (i.e., 40 nm
separation). The hybridized oligonucleotides were ligated for
30 min at 37◦C and then they were amplified for 100 min
at 37◦C. The result red fluorescence is from the labeled
oligonucleotides hybridized to the rolling circle amplification
product and it was visualized using a confocal microscope
(Leica TCS SP2, Germany). Maximum intensity projections of
all z-sections (0.4 µm) were obtained by ImageJ software and
puncta of maximum intensity projections were analyzed by
Duolink ImageTool software (Sigma-Aldrich, United States). As
a positive control we used the interaction between anti-MHC
and anti-vimentin antibodies. The negative control was obtained
using TRPC5 antigen together with anti-Orai-1 antibody, which
did not show any detectable PLA signal.
RNA Extraction and qRT-PCR Analysis
Rat’s hearts were washed in PBS, and immediately separated from
risk and remote zones. Each zone was cut in small pieces collected
in RNA later (Qiagen N.V., Germany), and processed according
to the extraction of RNA. Total RNA was extracted from tissues
by homogenization using tissuelyzer (Qiagen N.V., Germany)
with 1 ml of Trizol. After chloroform mix and centrifugation,
aqueous phase was transferred to “RNeasy mini kit” (Qiagen
N.V., Germany) columns and were continued according to the
manufacturer’s instructions. The ratio of absorbance at 260 and
280 nm (A260/A280) was used to assess the purity of RNA. RNA
concentrations were determined from absorbance at 260 nm
(A260). Two microgram of RNA were retrotranscribed to cDNA
with the “RT quantitec kit” (Qiagen N.V., Germany). Standard
qRT-PCRs were performed as described previously (Díaz et al.,
2017). Data analysis was made with the “Expression Suite”
software and fold change quantification was calculated using the
comparative cycle threshold CT (11CT) method. 18s rRNA
gene was used as endogenous control.
Gene Expression Assay by Array Card
qRT-PCR was performed with the use of a Viia7 Real-Time
PCR system (Applied Biosystems, United States) and Custom
TaqMan R© Array cards (384 wells) was designed to detect
expression of 45 genes of interest according to manufacturer’s
indication (Applied Biosystems, United States). PCR mix was
performed in a total volume of 125 µl, which included 2x Taqman
PCR master mix and 1 µg of RNA. Thermal cycling conditions
were as follows: 95◦C for 5 min, followed by 40 cycles of 95◦C for
10 s, and 60◦C for 30 s.
Western Blotting
Rat’s hearts were isolated, washed in PBS, and immediately
separated from risk and remote zones. Small pieces of heart
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were disrupted through high-speed shaking in plastic tubes
with stainless steel in the homogenizer tissuelyzer (Qiagen N.V.,
Germany). Protein samples were also processed from NRVMs
culture. Then protein extraction was carried out with 1 ml
of NP40 cell lysis buffer supplemented with inhibitor cocktail
(Roche, Switzerland) and 1% of PMSF and incubated for 30 min
on ice. After centrifugation, protein fractions were separated
and quantified by Bradford method. Similar amounts of protein
samples were subjected to SDS-PAGE (10% acrylamide) and
electrotransferred onto PVDF membranes. After blocking with
5% non-fat dry milk dissolved in Tris-buffered saline containing
0.1% Tween-20 (TTBS) for 1 h at 37◦C, membranes were probed
overnight at 4◦C with specific primary antibodies in TTBS
with 1% of BSA. After washing, membranes were incubated
for 45 min at room temperature with a horseradish peroxidase
conjugated anti IgG (Cell Signaling, United States). Detection
was performed with the enhanced chemiluminescence reagent
ECL-prime (Amersham Bioscience, United Kingdom) in the
ImageQuant LAS 4000 mini (GE Healthcare, United States).
For quantification, the images were analyzed with ImageJ
software using GAPDH or β-actin as housekeeping control.
Antibodies: TRPC1, TRPC4, TRPC5 and TRPC6 (Alomone
Labs, Israel), Orai1 (Novus Biologicals, United States), STIM1
(Sigma-Aldrich, United States) and GAPDH (Cell Signaling,
United States).
Statistical Analysis
Analyses were made with Origin 8.0 software. A sample size
calculation was performed prior the start of this study. Values
are reported as mean± SEM. Difference between two groups was
assessed with two-tailed unpaired Student’s t-test and between at
least three groups with one-way or two-way ANOVA for multiple
comparisons. The statistical significance was defined by a value
of: ∗p< 0.05, ∗∗p< 0.01, ∗∗∗p< 0.001.
RESULTS
Urocortin-2 Improves Heart’s
Performances, Decreases the Infarct
Size and Attenuates Fibrosis
The effect of Ucn-2 (150 µg/kg) infused 5 min before
the opening of LCA was evaluated in vivo in rat model
of I/R as indicated in Figure 1A. Figures 1B–D show
significant reduction in the contractile capacity of the heart
1 week after I/R as assessed by M-Mode echocardiography. As
depicted in Figures 1C,D, significant decrease in the Ejection
Fraction (EF = 56.9% ± 3.3) and the Fractional Shortening
(FS = 40.1% ± 3.4) was observed in I/R group compared to
Sham (EF = 71.8% ± 1.3 and FS = 50.7% ± 4.0). Meanwhile,
the infusion of rats with Ucn-2 before reperfusion recovered
significantly EF (64.12% ± 1.53), FS (47.6% ± 0.9) and
other hemodynamics parameters as summarized in Table 1.
Interestingly, the beneficial effects of a single infusion of
Ucn-2 on the ejection fraction and fractional shortening was
observed as early as 24 h after the intervention and was even
maintained 4 weeks after surgery (data not shown). Furthermore,
rats’ infusion with Ucn-2 decreased significantly the infarct
size associated with transient LCA ligation as illustrated in
Figure 1E.
Next, we examined I/R induced hypertrophy using
echocardiography and WGA staining. Figures 2A,B show a
significant increase in the thickness of left ventricle posterior
wall (LVPW) in rat from I/R group, but also in rats infused with
Ucn-2 (Figures 2A,B). The staining of heart’s section with WGA
confirms a significant increase of cell area in remote and risk
zones, both in I/R rats and in rats treated with Ucn-2 as shown in
Figures 2C,D.
Afterward, we evaluated fibrosis in vivo 1 week after I/R
using cardiovascular magnetic resonance performed with delayed
enhancement following the administration of gadolinium.
Figures 2E,F show the appearance of significant reactive fibrosis
both in risk and remote zones as early as 1 week after surgery.
Meanwhile, rats’ infusion with Ucn-2 efficiently prevented this
fibrosis in both areas.
Altogether, these data indicate that the administration of Ucn-
2 in reperfusion recovers significantly cardiac hemodynamic
functions, reduces infarct size, attenuates fibrosis but it doesn’t
prevent cardiac hypertrophy.
Urocortin-2 Prevents I/R Dysregulation
of [Ca2+]i Handling in Cardiomyocytes
Since Ca2+ homeostasis is crucial for heart contractility, we
examined [Ca2+]i handling in cardiomyocytes isolated from
I/R rats after Ucn-2 infusion. Figure 3A shows representative
line-scan Ca2+ fluorescence images obtained after electric
field stimulation at 1 Hz. As indicated, rats undergoing I/R
showed significant decrease in cellular contractions measured
as cell shortening (Figure 3B) and in the amplitude of
[Ca2+]i transients recorded in isolated cardiac myocytes from
remote and risk zones (Figure 3C), compared to Sham. SR
Ca2+ load and the decay time, analyzed by caffeine-evoked
TABLE 1 | Echocardiographic parameters of rat’s model of I/R.
Parameter HR (bum) EF (%) FS (%) LVESD (mm) LVEDD (mm) SV (µL) DV (µL) n
Sham 436 ± 5.3 71.8 ± 1.2 50.7 ± 4.0 2.7 ± 0.2 6.4 ± 0.1 119.5 ± 5.5 427.4 ± 19.9 8
I/R 424.2 ± 6.3 54.5 ± 2.8∗ 40.1 ± 3.4∗ 4.1 ± 0.3 ∗ ∗ 6.8 ± 0.2∗ 207.8 ± 24.01∗ 494.5 ± 36.4 15
I/R + Ucn-2 416.3 ± 3.8 65.2 ± 1.1∗ 47.6 ± 0.9∗ 3.5 ± 0.1∗ 5.9 ± 0.1 142.7 ± 7.8 ∗ ∗| 397.4 ± 13.8 ∗ ∗ 16
Data summary (mean± SEM) of rats’ hemodynamic parameters evaluated in “Sham,” “I/R” and “I/R+ Ucn-2” experimental groups after 1 week I/R intervention. HR, Heart
Rate; EF, Ejection Fraction; FS, Fractional Shortening; LVESD, Left-Ventricle End-Systolic Diameter; LVEDD, Left-Ventricle End-Diastolic Diameter; SV, Systolic Volume;
DV, Diastolic Volume. Data are mean ± SEM. ∗ and ∗∗ Indicate significance at p < 0.05 and p < 0.01 respectively. IR was compared with Sham and I/R+Ucn-2 vs. I/R.
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FIGURE 2 | Urocortin-2 preserves cardiac hypertrophy, but it prevents fibrosis. (A,B) Representative and summary data of two-dimensional echocardiographic
images in parasternal long-axis view of left ventricle taken from “Sham” (white bar, n = 8), “I/R” (gray bar, n = 15) and “I/R + Ucn-2” (hatched gray bar, n = 10) groups.
(C,D) Representative images and summary data of staining with Wheat Germ Agglutinin (WGA) of heart section taken from risk (red) and remote (green) zones from
I/R’s group (n = 6). Hatched bars are for I/R + Ucn-2 group. (E) In vivo cardiovascular magnetic resonance showing original images with mark of gadolinium
enhancement area in remote and risk zones taken from I/R (up) and from I/R + Ucn-2 (down). (F) Bar graph summarizing fibrosis area (mm2) in remote (green) and
risk (red) zones. LV, Left Ventricle; RV, Right Ventricle; LVPW, Left Ventricle Posterior Wall; IVS, Interventricular Septum; Ao, Aorta; LA, Left Atrium. Data are presented
as mean ± SEM. ∗ Indicates significance at p < 0.05.
[Ca2+]i transients, were also significantly affected by I/R,
being more prominent in risk than in remote zone as
shown in Supplementary Figures 1A–C. Interestingly, the
administration of Ucn-2 to I/R rats recovered significantly
cell shortening and the amplitude of [Ca2+]i transients as
illustrated in Figures 3A–C, confirming that Ucn-2 is able
to modulate of [Ca2+]i when administrated in the onset of
reperfusion.
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FIGURE 3 | Urocortin-2 recovers the amplitude of [Ca2+] transients and the contraction of cardiomyocytes decreased under I/R. (A) Line-scan images during field
stimulation at 1 Hz of cardiomyocyte isolated from “Sham” rats and from remote and risk zones of rat exposed to I/R infused or not with Ucn-2 (150 µg/Kg) 5 min
before reperfusion. (B) Bar graph showing cellular shortening expressed in percentage of cell length in each experimental group. “Sham,” blue bar; “I/R” remote,
green bar; and risk, red bar. Hatched bars are for “I/R + Ucn-2.” (C) Average of the amplitude of [Ca2+]i transients measured as peak of F/F0, where F is the
fluorescence and F0 is the fluorescence in the diastolic period. Data are from 6 “Sham” rats (n = 51 cells), 7 “I/R” rats (n = 32–42 cells) and 6 rats of “I/R + Ucn-2”
group (n = 18–20 cells). Data are presented as mean ± SEM. ∗ Indicates significance at p < 0.05.
Urocortin-2 Regulates the Expression of
Proteins Involved in Ca2+ Homeostasis
In order to determine the molecular participants involved in
I/R induced alteration of [Ca2+]i homeostasis, we performed
a PCR-based micro-array to evaluate the expression of 45
genes related to Ca2+ homeostasis in risk and remote zones.
Table 2 shows that 14 of the examined genes were significantly
upregulated either in risk or in remote zones as compared
to Sham. Interestingly, most of the upregulated genes belong
to TRPC family (TRPC1/3/5/6) and to the store operated
Ca2+ signaling pathway (Orai1/2 and STIM1/2). Therefore,
we sought to validate the expression of these genes and
we explored their possible regulation by the infusion of
Ucn-2 in rat’s model of I/R. Figures 4A,C confirm that
both mRNA and protein expression of TRPC5 were increased
significantly in I/R rats in remote and/or risk zones. Similarly,
the expression of Orai1 was increased especially in risk zone
at the protein level (Figures 4B,D). Importantly, I/R rats’
infusion with Ucn-2 efficiently decreased the overexpression
of TRPC5 and Orai1 in both zones. Ucn-2 treatment also
downregulated the expression of STIM1 particularly in risk zone
at mRNA and protein levels, meanwhile it didn’t affect the
expression of TRPC6 (Figures 4E–H). In contrast, Ucn-2 failed
to prevent I/R-evoked upregulation of other proteins such as
Epac and NCX observed especially in risk zones (Supplementary
Figure 2).
These data indicate that Ucn-2 is able to prevent I/R-evoked
alteration of the expression of several proteins involved in the
regulation of [Ca2+]i homeostasis, which might play a significant
role in heart contraction.
Urocortin-2 Decreases Store-Operated
Ca2+ Entry Induced by I/R in NRVMs
Taking into consideration the previous data demonstrating
that I/R promotes the alteration of several cationic channels
related to SOCC pathway, we examined whether I/R promotes
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TABLE 2 | List of the expression of genes dysregulated after I/R.
Risk zone Remote zone
Gene Fold change p-value Fold change p-value
Serca 1.28 ± 0.13 0.179 2.12 ± 0.3 0.001
Cacna1c 1.39 ± 0.18 0.079 2.07 ± 0.34 0.001
Orai1 1.45 ± 0.11 0.002 1.21 ± 0.08 0.075
Rapgef3 1.47 ± 0.16 0.002 1.28 ± 0.09 0.022
Trpc1 1.57 ± 0.11 0.002 1.61 ± 0.16 0.002
Hcn4 1.71 ± 0.36 0.033 2.76 ± 0.48 0.001
Trpc5 1.71 ± 0.56 0.172 10.87 ± 7.49 0.020
Trpc3 1.78 ± 0.21 0.001 1.42 ± 0.23 0.034
Slc8a1 1.83 ± 0.18 0.001 2.27 ± 0.23 0.001
Trpc4 2.08 ± 0.2 0.008 1.83 ± 0.19 0.041
Stim1 2.15 ± 0.27 0.001 1.72 ± 0.23 0.003
Stim2 2.38 ± 0.3 0.001 1.56 ± 0.12 0.001
Trpc6 3.89 ± 0.88 0.001 1.03 ± 0.16 0.381
Orai2 4.07 ± 1.35 0.001 1.22 ± 0.24 0.197
The PCR-based array was conducted in heart’s samples taken from “Sham,”
and from risk and remote zones of “I/R” rats model. Data are expressed in
fold change and in mean ± SEM (n = 4). Bold letters are for genes with
significant changes at p < 0.05. Genes name: Cacna1c, Calcium voltage-gated
channel subunit alpha1 C; Hcn4, Hyperpolarization activated cyclic nucleotide
gated potassium channel 4 (Ifunny); Orai1/2, ORAI calcium release-activated calcium
modulator 1/2; Rapgef3, Rap guanine nucleotide exchange factor 3 (Epac);
Serca, Sarco/endoplasmic reticulum Ca2+-ATPase; Slc8a1, Solute carrier family
8 (sodium/calcium exchanger) member 1; Stim1/2, Stromal interaction molecule
1/2; Trpc1/3/5/6, Transient receptor potential cation channel subfamily C member
1/3/5/6.
SOCE and if Ucn-2 regulates SOCE. We used a classical
protocol for SOCC activation in NRVMs under I/R in vitro
as illustrated in Figure 5A. Figure 5B shows that the addition
of thapsigargin (TG, 2 µM), in presence of nifedipine (NIF,
10 µM), to control NRVMs evoked significant increase in
the [Ca2+]i after Ca2+ restoration. Importantly, when NRVMs
were subjected to I/R TG-induced larger augmentation of
[Ca2+]i amplitudes compared to control, which was significantly
blunted in cells pre-treated with SOCC inhibitors GSK-7975A
(10 µM) and SKF-96365 (40 µM). Furthermore, we measured
Mn2+-induced quenching of Fura-2 fluorescence in NRVMs
treated with TG to obtain direct evidences that I/R promoted
exacerbated SOCE due to SOCC activity. Figure 5C shows
that TG (2 µM) promoted significant Mn2+ influx as
observed by fast decay of Fura-2 fluorescence after Mn2+
(500 µM) addition in NRVMs submitted to I/R compared
to control. The observed Mn2+ influx was significantly
reduced by GSK-7975A and SKF-96365 confirming SOCE
stimulation.
Interestingly, the addition of Ucn-2 (10 nM) to
NRVMs prevented the augmented TG-induced Ca2+
and Mn2+ influx under I/R (Figures 5B,C). Besides,
NRVMs pre-treatment with astressin (1 µM), inhibitor of
CRF-R2, abolished the effect of Ucn-2 on Ca2+ and Mn2+
influx, confirming that Ucn-2 acts through its receptor
CRF-R2 to inhibit SOCE exacerbated by I/R. These results
demonstrate that I/R potentiates SOCE, which is inhibited by
Ucn-2.
Urocortin-2 Attenuated -SOCE Is
Dependent on TRPC5 and Orai1
Channels
Based on the obtained data in adult cardiomyocytes, where
we observed significant changes in the expression of TRPC5
and Orai1, we evaluated whether they are involved in SOCE
induced by I/R in NRVMs. Firstly, Figure 6A shows that I/R
increased the expression of TRPC5 and Orai1 in NRVMs.
Importantly, cells treatment with Ucn-2 (10 nM) inhibited
completely I/R-evoked TRPC5 and Orai1 overexpression. In
contrast, cells pre-treatment with astressin (1 µM) blocked the
effect of Ucn-2 on the expression of TRPC5 and Orai1. Secondly,
we examined SOCE in NRVMs transfected with siRNA against
TRPC5 and Orai1. Figures 6B,C shows that I/R-induced Ca2+
influx was completely inhibited when TRPC5 and Orai1 genes
were silenced, confirming the implication of these proteins in I/R
inducing exacerbated SOCE. Interestingly, the effect of TRPC5
and Orai1 downregulation was very similar to the inhibitory
effect of Ucn-2 in SOCE.
In light of the previous data, we examined the endogenous
subcellular localization of TRPC5 and Orai1 and their possible
interaction by the use of in situ PLA. Figures 7A,C show
PLA red puncta in control NRVMs incubated with primary
antibodies against TRPC5 and Orai1 indicating their close
proximity. Furthermore, the number of PLA red puncta
enhanced significantly under I/R, suggesting an increase of
TRPC5 and Orai1 interaction. In contrast, NRVMs incubation
with Ucn-2 during I/R significantly decreased puncta signals,
indicating less interaction between both proteins. As a control,
Figures 7B,C show that PLA signal decreased significantly
in NRVMs pre-incubated with control peptide antigen of
TRPC5 in presence of both TRPC5 and Orai1 antibodies.
Taken together, these data suggest that TRPC5 interacts with
Orai1 in basal conditions but they increase their association
under I/R process, which certainly will promote Ca2+ entry
and might be related to the abnormal [Ca2+]i signaling in
reperfused heart. These data shows that Ucn-2 efficiently
inhibited SOCE through TRPC5 and Orai1 downregulation and
interaction.
DISCUSSION
An effective and early coronary revascularization is considered
the best therapy to limit the extent of myocardial infarction.
Nevertheless, heart’s reperfusion is paradoxically associated with
adverse effects that harm its adequate function (Hausenloy
et al., 2017). Therefore, strategies of cardioprotection still
remain of major interest to limit heart’s damage from I/R
injury and the adverse ventricular remodeling (Heusch, 2015).
Our study provides several new data describing that a single
i.v. administration of Ucn-2, right before revascularization,
protects efficiently the heart from I/R lesions. As summarized
in Figure 8, Ucn-2 beneficial effects involve the recovery of
cardiac contraction, the attenuation of fibrosis extension and
the regulation of [Ca2+]i signaling. We also provide the first
quantitative description of Ucn-2 effects on I/R-activated SOCE
Frontiers in Physiology | www.frontiersin.org 9 July 2018 | Volume 9 | Article 813
fphys-09-00813 June 29, 2018 Time: 19:12 # 10
Domínguez-Rodríguez et al. Ucn-2, Ca2+ and Cardiac Remodeling
FIGURE 4 | Urocortin-2 regulates the expression of TRPC5, Orai1 and STIM1. (A,B,E,F) Bar graphs showing relative fold change of mRNA levels of TRPC5, Orai1,
STIM1 and TRPC6 respectively. (C,D,G,H) Representative immunoblots (top) and quantification (bottom) of protein expression of TRPC5, Orai1, STIM1 and TRPC6
respectively assessed by Western Blots and normalized to their corresponding β-actin expression. Sample were from “Sham” (blue bar); remote (green) and risk (red)
zones processed 1 week after I/R. Hatched bars are for rats infused with Ucn-2 (150 µg/Kg). Values are mean ± SEM from 4 to 6 rats. ∗, ∗∗, ∗∗∗ Indicate
significance at p < 0.05, p < 0.01, and p < 0.001 respectively.
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FIGURE 5 | Urocortin-2 inhibits I/R-induced exacerbated SOCE in NRVMs. (A) Experimental protocol of cultured NRVMs subjected to I/R and Ucn-2 (10 nM).
(B) Representative traces (left) showing the changes in [Ca2+]i in Fura-2 loaded NRVMs, presented as ratio (F340/F380). In right, bar graph illustrating data summary
of experiments as in left. (C) Representative traces (left) and data summary (right) of Mn2+ influx-induced Fura-2 quenching expressed in percent change of F360
fluorescence after the administration of Mn2+ (500 µM). Thapsigargin (TG, 2 µM) and nifedipine (NIF, 10 µM) were applied 4 min in the absence of extracellular Ca2+
and then Ca2+ (1.8 mM) was added as indicated. “Control” indicates responses of NRVMs to TG, “I/R” is for NRVMs under protocol of I/R, “I/R+Ucn-2” is NRVMs
treated with Ucn-2 during I/R, “I/R+Ucn-2+Ast” indicates NRVMs pre-incubated with astressin (0.5 µM) before Ucn-2 addition in I/R, “I/R+SKF” indicates NRVMs
pre-incubated with SKF-96365 (40 µM), and “I/R + GSK” indicates NRVMs pre-incubated with GSK-7975A (10 µM). n = 100–250 cells from 5–10 cultures. Data are
mean ± SEM. ∗, ∗∗, ∗∗∗ indicate significance at p < 0.05, p < 0.01, and p < 0.001 respectively.
in the heart, which correlated with the decrease in the expression
and activity of TRPC5 and Orai1 channels either in risk or in
remote zones.
We demonstrated that as soon as 1 week after I/R, significant
structural and molecular alterations happen in risk zone, close
to the infarcted area, but also in remote zone that is supposed
to be healthy. Hypertrophy and fibrosis affected not only to the
infarcted area but also the non-infarcted area, which is probably
due to the initial multiphase reparative responses. Indeed, it is
well known that the healing process triggered after a myocardial
infarct is accomplished by a series of molecular reactions. These
facts are: the release of cytokines, matrix metalloproteinases
and growth factors; the recruitment of inflammatory cells; the
differentiation of macrophages, mast cells and myofibroblasts, as
well as the formation of new vessels and scar tissue (Talman and
Ruskoaho, 2016; Montecucco et al., 2017). Consistent with our
findings, these molecular reactions affect equally the damaged
tissue in risk zone and the preserved tissue in remote zone,
eliciting considerable heart adverse remodeling. Importantly,
rats’ infusion with Ucn-2 prevented fibrosis in both areas in
agreement with previous studies which showed that Ucn-2
decreased collagen deposition in the heart and suppressed
the expression of fibrosis’ markers as TGF-β1 and collagen-1
(Rademaker et al., 2015). In contrast, Ucn-2 didn’t inhibit
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FIGURE 6 | Urocortin-2 inhibition of I/R-induced SOCE involves TRPC5 and Orai1 activation. (A) Representative Western Blot (top) and summary analysis (bottom)
showing the expression of TRPC5 and Orai1 normalized to GAPDH examined in untreated NRVMs (control); after I/R, and in cells treated with Ucn-2 ± 0.5 µM of
astressin (I/R + Ucn-2; I/R + Ucn-2 + Ast). (B) Representative Western Blot (top) and summary analysis (bottom) showing the expression of TRPC5 and Orai1
normalized to GAPDH examined in untreated NRVMs (control); and in cells transfected with siRNA against Orai1 (siOrai1) and TRPC5 (siTRPC5). (C) Representative
traces and average data of TG-induced Ca2+ influx in Fura-2 loaded NRVMs from “Control,” “I/R” and “I/R+Ucn-2,” and in cells transfected with siRNA of TRPC5
“I/R+siTRPC5” and Orai1 “I/R+siOrai1.” n = 100–200 cells from 6 cultures. Data are mean ± SEM. ∗, ∗∗, ∗∗∗ indicate significance at p < 0.05, p < 0.01, and
p < 0.001 respectively.
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FIGURE 7 | I/R enhances TRPC5 and Orai1 co-localization in cardiomyocytes. (A) Representative images of NRVMs using primary antibodies against TRPC5 and
Orai1 conjugated with the appropriate Proximity Ligation Assay (PLA) probes, from untreated “control” cells, “I/R” cells and from cells incubated with Ucn-2 (10 nM;
I/R + Ucn-2). The left panels show NRVMs images when antibodies were conjugated with PLA probes; middle panels show merged images with DAPI (blue); and
right panels show Bright Field (BF) images. Red puncta indicate that proteins are in close proximity (<40 nm). (B) Images from NRVMs pre-incubated with control
peptide antigen of TRPC5, anti-TRPC5 and with anti-Orai1 primary antibodies (negative control). (C) Bar graph summarizes the mean number of PLA signals in
different experimental groups. n = 3 cell cultures. Data are presented as mean ± SEM normalized to positive control determined by the colocalization of vimentin and
α-MHC (α Myosin heavy chain). ∗, and ∗∗∗ indicate significance at p < 0.05 and p < 0.001 respectively.
FIGURE 8 | Schematic model illustrating the cardioprotection effect of Ucn-2 from I/R injuries. Left panel summarizes the effect of I/R in rats. I/R promotes fibrosis,
hypertrophy and increases the infarct size. I/R also decreases heart’s contractility (ejection fraction and cell shortening) and [Ca2+]i transients. In addition, we
demonstrated that I/R potentiates SOCE and upregulated several ion channels, such as Orai1 and TRPC5. Right panel illustrates the effects of the addition of Ucn-2
at the onset of reperfusion. Ucn-2 inhibits fibrosis and decreases the infarct size; it recovers significantly heart’s contraction and the amplitude of [Ca2+]i transients.
Moreover, Ucn-2 blocks I/R-evoked exacerbated SOCE and it inhibits I/R-induced Orai1 and TRPC5 upregulation and interaction.
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I/R-induced cardiac hypertrophy. Our observation agrees with
others reports that described pro-hypertrophic effects of Ucn
peptides in cultured NRVMs (Ikeda et al., 1998; Chanalaris et al.,
2005). Indeed, isoforms of Ucn stimulated several markers of
hypertrophy, increased cell size and promoted embryonic genes
β-Myosin Heavy Chain (β-MHC) as well as Atrial and B-type
Natriuretic Peptides (ANP and BNP). Nevertheless, other reports
suggested an anti-hypertrophic action of chronic infusion of
Ucn-2 in a rat model of arterial hypertension (Dieterle et al.,
2009) and in mice model of heart infarct (Ellmers et al., 2015).
Perhaps, Ucn-2 preserved the observed cardiac hypertrophy to
maintain its compensatory effect at least in the early stage of heart
remodeling as described previously (Rubin et al., 1983).
Cardiac dysfunction in reperfused hearts has been also
related to cardiac [Ca2+]i mishandling (Garcia-Dorado et al.,
2012). Several mechanisms have been considered to explain
the alteration of [Ca2+]i during reperfusion and the most
common changes associated with I/R are usually linked with
acidosis, excitation-contraction coupling disruption, depression
of SERCA activity and/or activation of NCX reverse mode
(Inserte et al., 2002). In this way, we showed that several
parameters of [Ca2+]i homeostasis were significantly altered in
risk zones, but unexpectedly also in remote zones. Furthermore,
we determined significant changes in the expression of key
proteins involved in SOCE pathway, such as Orai1, STIM1 and
TRPC channels.
Compelling evidences demonstrated that TRPC and SOCC
contributes to different cardiac pathology; nevertheless, their
role in I/R is less explored (Smani et al., 2015; Eder, 2017).
Here, we used a combination of functional Ca2+ imaging study,
biochemical and immunostaining approaches to confirm that
SOCE is observed and even potentiated by I/R in NRVMs.
We demonstrated that widely used inhibitors of SOCC blocked
TG-induced Ca2+ and Mn2+ influx, confirming SOCE activation
under I/R. We specifically showed a pivotal role of Orai1 and
TRPC5 as they were upregulated by I/R both in adult cardiac
tissue and in NRVMs. We determined that I/R induced an
exacerbated SOCE and an upregulation of TRPC5 and Orai1
which may objectively explain the significant increase of TRPC5
and Orai1 colocalization and interaction under I/R. It is well
accepted that Orai1 is required for SOCE in neonatal and adult
cardiomyocytes; however, the implication of TRPC5 in SOCE
is less studied (Smani et al., 2015; Avila-Medina et al., 2018).
Orai1 likely interacts with different TRPC to form a non-selective
SOCC especially in excitable cells (Bush et al., 2006; Liao et al.,
2008). A recent study showed that aldosterone enhanced SOCE
and increased the expression of STIM1, TRPC1, TRPC4, TRPC5
and Orai1 channels (Sabourin et al., 2016). Others showed that
TRPC1 and TRPC4 activation are associated with a passive
Ca2+ influx induced by angiotensin II or isoproterenol, and are
related to maladaptive cardiac hypertrophy (Camacho Londoño
et al., 2015). In our experimental conditions, we did not observe
significant changes in the expression of TRPC1 and TRPC4 under
I/R (Data not shown). However, we demonstrated that TRPC5
and Orai1 are required for SOCE since their gene’s silencing
inhibited completely I/R-induced SOCE. We also showed for
the first time that Orai1 and TRPC5 are distributed in close
sub-membrane domains in cardiac myocytes. Furthermore, we
showed that TRPC5 and Orai1 increased their colocalization
under I/R, which might explain the observed exacerbated
SOCE.
Interestingly, we showed that i.v. infusion or cells treatment
with Ucn-2 inhibited I/R-induced upregulation of TRPC5 and
Orai1 in cardiac tissue isolated from rats’ I/R model and
in NRVMS subjected to I/R in vitro. Actually, in NRVMs
Ucn-2 prevented I/R-induced upregulation of TRPC5 and
Orai1, inhibited I/R-evoked exacerbated SOCE, and significantly
decreased the interaction between TRPC5 and Orai1. These
effects were dependent on CRF-R2 activation since its inhibition
blocked efficiently Ucn-2 actions. Our data are consistent
with previous reports that showed Ucn-1 inhibition of SOCE
in coronary smooth muscle cells (Smani et al., 2007) and
skeletal muscle (Reutenauer-Patte et al., 2012). In addition to
TRPC5 involvement in SOCE, several reports demonstrated
that TRPC5 is sensitive to reactive oxygen species (ROS)
(Wong et al., 2010; Shimizu et al., 2014), what can be
triggered under I/R. Therefore, Ucn-2 downregulation of TRPC5
might mitigate the effect of ROS on cardiac cells integrity
under I/R.
Taken together, our findings highlight new unexpected aspects
of Ucn-2 role in cardiac protection. Ucn-2 improves cardiac
functions and remodeling; modulates [Ca2+]i; and inhibits
TRPC5 and Orai1 dependent SOCE. These protective effects,
together with others Ucn-2’s actions including vasorelaxation
of human coronary artery (Smani et al., 2011), its positive
inotropism (Smani et al., 2010) or its regulation of endocrine
and renal effects (Rademaker et al., 2011), suggest that
Ucn-2 is a promising and valuable therapeutic drug to
mitigate cardiac dysfunction in post-STEMI patients. Actually,
recent reports showed that Ucn-2 administration improved
left ventricle contractility in patients with decompensated
or chronic heart failure (Chan et al., 2013; Stirrat et al.,
2016).
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